NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status
about
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesMedical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).
P2860
NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@ast
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@en
type
label
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@ast
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@en
prefLabel
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@ast
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@en
P2093
P2860
P1476
NCCTG N0821 (Alliance): a phas ...... r with good performance status
@en
P2093
Alex A Adjei
Araba A Adjei
Daniel Anderson
Gamini Soori
Grace K Dy
Helen J Ross
Jeffrey Meyers
Julian R Molina
Marie Christine Aubry
Rafat Ansari
P2860
P304
P356
10.1097/JTO.0000000000000217
P577
2014-08-01T00:00:00Z